TREATMENT READING
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
8 studies cited in this topic · see design and results →
Explore 4 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
Certain factors affect prognosis (chance of recovery) and treatment options.
Medulloblastoma, other CNS embryonal tumors, and pineoblastoma in children are treated based on the tumor type and the child's age.
Treatment of medulloblastoma in children older than 3 years also depends on whether the tumor is average risk or high risk.
Average risk
High risk
The results of the tests and procedures done to diagnose medulloblastoma, other CNS embryonal tumors, and pineoblastoma in children are used to plan cancer treatment.
Sometimes childhood medulloblastoma and other central nervous system embryonal tumors come back after treatment.
Treatment Option Overview
Key Points
There are different types of treatment for children who have medulloblastoma and other central nervous system (CNS) embryonal tumors.
Children who have medulloblastoma, other CNS embryonal tumors, and pineoblastoma should have their treatment planned by a team of health care providers who are experts in treating brain tumors in children.
The following types of treatment may be used:
Surgery
Radiation therapy
Chemotherapy
High-dose chemotherapy with autologous stem cell rescue
Targeted therapy
New types of treatment are being tested in clinical trials.
Treatment of Childhood Medulloblastoma
Treatment of Other CNS Embryonal (nonmedulloblastoma) Tumors in Children
Treatment of Childhood Pineoblastoma
Treatment of Recurrent Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors
The tumor and the treatment may cause symptoms that continue after treatment ends.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle